Nordea Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.8M | Sell |
28,031
-113,588
| -80% | -$42.1M | 0.01% | 447 |
|
|
2026
Q1 | $40.9M | Sell |
141,619
-198,648
| -58% | -$65.3M | 0.04% | 289 |
|
|
2025
Q4 | $119M | Sell |
340,267
-68,527
| -17% | -$23.2M | 0.1% | 192 |
|
|
2025
Q3 | $131M | Sell |
408,794
-386,329
| -49% | -$120M | 0.11% | 183 |
|
|
2025
Q2 | $308M | Sell |
795,123
-278,050
| -26% | -$112M | 0.29% | 96 |
|
|
2025
Q1 | $468M | Sell |
1,073,173
-110,133
| -9% | -$44.2M | 0.49% | 48 |
|
|
2024
Q4 | $439M | Sell |
1,183,306
-48,932
| -4% | -$20.5M | 0.46% | 51 |
|
|
2024
Q3 | $640M | Sell |
1,232,238
-105,950
| -8% | -$56.6M | 0.73% | 25 |
|
|
2024
Q2 | $722M | Sell |
1,338,188
-159,326
| -11% | -$84.2M | 0.85% | 19 |
|
|
2024
Q1 | $779M | Sell |
1,497,514
-134,609
| -8% | -$66.9M | 0.92% | 18 |
|
|
2023
Q4 | $768M | Buy |
1,632,123
+8,314
| +0.5% | +$3.84M | 0.98% | 19 |
|
|
2023
Q3 | $719M | Sell |
1,623,809
-11,926
| -0.7% | -$5.41M | 1% | 18 |
|
|
2023
Q2 | $718M | Buy |
1,635,735
+48,323
| +3% | +$22.3M | 0.98% | 20 |
|
|
2023
Q1 | $731M | Buy |
1,587,412
+27,779
| +2% | +$13.2M | 1.07% | 17 |
|
|
2022
Q4 | $797M | Sell |
1,559,633
-49,310
| -3% | -$25M | 1.24% | 14 |
|
|
2022
Q3 | $749M | Sell |
1,608,943
-99,805
| -6% | -$47.8M | 1.21% | 16 |
|
|
2022
Q2 | $830M | Sell |
1,708,748
-261,154
| -13% | -$129M | 1.23% | 16 |
|
|
2022
Q1 | $983M | Sell |
1,969,902
-147,990
| -7% | -$67.6M | 1.23% | 11 |
|
|
2021
Q4 | $989M | Buy |
2,117,892
+13,144
| +0.6% | +$5.53M | 1.18% | 13 |
|
|
2021
Q3 | $817M | Sell |
2,104,748
-149
| -0% | -$56.6K | 1.06% | 16 |
|
|
2021
Q2 | $804M | Sell |
2,104,897
-42,950
| -2% | -$16.4M | 1.08% | 18 |
|
|
2021
Q1 | $776M | Buy |
2,147,847
+82,797
| +4% | +$26.6M | 1.13% | 18 |
|
|
2020
Q4 | $663M | Sell |
2,065,050
-209,847
| -9% | -$64.4M | 1.07% | 19 |
|
|
2020
Q3 | $607M | Sell |
2,274,897
-2,330,481
| -51% | -$627M | 1.14% | 21 |
|
|
2020
Q2 | $1.18B | Buy |
4,605,378
+2,204,964
| +92% | +$588M | 1.23% | 19 |
|
|
2020
Q1 | $546M | Buy |
2,400,414
+31,999
| +1% | +$8.72M | 1.31% | 18 |
|
|
2019
Q4 | $721M | Sell |
2,368,415
-63,567
| -3% | -$17.5M | 1.44% | 13 |
|
|
2019
Q3 | $579M | Buy |
2,431,982
+131,386
| +6% | +$36M | 1.26% | 18 |
|
|
2019
Q2 | $650M | Sell |
2,300,596
-190,775
| -8% | -$52.1M | 1.45% | 13 |
|
|
2019
Q1 | $715M | Sell |
2,491,371
-50,563
| -2% | -$14.6M | 1.49% | 9 |
|
|
2018
Q4 | $668M | Sell |
2,541,934
-258,101
| -9% | -$71M | 1.59% | 10 |
|
|
2018
Q3 | $767M | Sell |
2,800,035
-114,513
| -4% | -$29.7M | 1.58% | 10 |
|
|
2018
Q2 | $694M | Sell |
2,914,548
-233,998
| -7% | -$54.2M | 1.66% | 9 |
|
|
2018
Q1 | $692M | Sell |
3,148,546
-573,722
| -15% | -$135M | 1.66% | 12 |
|
|
2017
Q4 | $838M | Sell |
3,722,268
-493,301
| -12% | -$105M | 1.98% | 8 |
|
|
2017
Q3 | $800M | Buy |
4,215,569
+339,111
| +9% | +$64.5M | 1.92% | 9 |
|
|
2017
Q2 | $729M | Sell |
3,876,458
-1,135,312
| -23% | -$204M | 1.84% | 10 |
|
|
2017
Q1 | $829M | Sell |
5,011,770
-1,184,462
| -19% | -$188M | 2.19% | 8 |
|
|
2016
Q4 | $891M | Sell |
6,196,232
-855,344
| -12% | -$115M | 2.36% | 7 |
|
|
2016
Q3 | $884M | Buy |
7,051,576
+630,598
| +10% | +$81.4M | 2.29% | 9 |
|
|
2016
Q2 | $843M | Buy |
6,420,978
+1,642,691
| +34% | +$225M | 2.36% | 9 |
|
|
2016
Q1 | $664M | Buy |
4,778,287
+369,596
| +8% | +$49.4M | 2% | 7 |
|
|
2015
Q4 | $615M | Buy |
4,408,691
+726,268
| +20% | +$100M | 2.09% | 6 |
|
|
2015
Q3 | $516M | Buy |
3,682,423
+545,819
| +17% | +$82M | 1.9% | 9 |
|
|
2015
Q2 | $515M | Buy |
3,136,604
+87,745
| +3% | +$14M | 1.8% | 10 |
|
|
2015
Q1 | $471M | Buy |
3,048,859
+119,371
| +4% | +$17M | 1.69% | 10 |
|
|
2014
Q4 | $368M | Sell |
2,929,488
-386,703
| -12% | -$47.8M | 1.36% | 19 |
|
|
2014
Q3 | $397M | Sell |
3,316,191
-531,340
| -14% | -$60.9M | 1.59% | 15 |
|
|
2014
Q2 | $414M | Buy |
3,847,531
+428,694
| +13% | +$44.2M | 1.73% | 9 |
|
|
2014
Q1 | $340M | Buy |
3,418,837
+206,650
| +6% | +$18.7M | 1.59% | 14 |
|
|
2013
Q4 | $297M | Buy |
3,212,187
+161,173
| +5% | +$14.3M | 1.48% | 14 |
|
|
2013
Q3 | $255M | Buy |
3,051,014
+107,237
| +4% | +$9.19M | 1.42% | 16 |
|
|
2013
Q2 | $241M | Buy |
+2,943,777
| New | +$220M | 1.49% | 15 |
|
Other funds holding ELV
Nordea Investment Management's ELV Position: Q2 2026 in Review
Nordea Investment Management reduced its Elevance Health (ELV) stake by 80% in Q2 2026, selling an estimated $42.1M and leaving 28,031 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #447.
Nordea Investment Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.18B in Q2 2020. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Nordea Investment Management held 28,031 shares of Elevance Health worth $10.8M as of Q2 2026.
- Nordea Investment Management sold 113,588 Elevance Health shares in Q2 2026, an estimated $42.1M.
- Elevance Health made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #447 holding.
- Nordea Investment Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Nordea Investment Management's Elevance Health position peaked at $1.18B in Q2 2020.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.